Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats

By Orhan Bulent   Yalcin Suayib   Nurlu Gulay   Zeybek Dilara   Muftuoglu Sevda  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 197-203

Humana Press, Inc

Access to resources Recommend Favorite

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

By Kroep J.   Smit E.   Giaccone G.   Born K.   Beijnen J.   Groeningen C.   Vijgh W.   Postmus P.   Pinedo H.   Peters G.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 509-516

Springer Publishing Company

Access to resources Recommend Favorite

Two Sequential Studies for Primary Peritoneal Carcinoma: Induction with Weekly Cisplatin Followed by either Cisplatin-Doxorubicin-Cyclophosphamide or Paclitaxel-Cisplatin

By Piver M.S.   Eltabbakh G.H.   Hempling R.E.   Recio F.O.   Blumenson L.E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

By Goldberg J.M.   Piver M.S.   Hempling R.E.   Recio F.O.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 312-317

Academic Press

Access to resources Recommend Favorite

Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity

By van den Bent M.J.   van Putten W.L.J.   Hilkens P.H.E.   de Wit R.   van der Burg M.E.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 387-391

Elsevier

Access to resources Recommend Favorite